These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 36200230)

  • 1. Certification program of Addiction Centres for hepatitis C virus elimination in Spain. HepCelentes Project.
    Colom J; Torrens M; Rodríguez-Cejas Á; Aguilar I; Álvarez-Crespo R; Armenteros L; Ayala V; Cantero H; Casado Gómez MÁ; Crespo J; Estévez J; García-Samaniego J; Hernández-Guerra M; Mur C; Pérez-Bech E; Ricote M; Pineda JA
    Adicciones; 2024 Jun; 36(2):129-144. PubMed ID: 36200230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elimination of hepatitis C. Positioning document of the Spanish Association for the Study of the Liver (AEEH).
    Crespo J; Albillos A; Buti M; Calleja JL; García Samaniego J; Hernández Guerra M; Serrano T; Turnes J; Acín E; Berenguer J; Berenguer M; Colom J; Fernández I; Fernández Rodríguez C; Forns X; García F; Grandados R; Lazarus JV; Molero JM; Molina E; Pérez Escanilla F; Pineda JA; Rodríguez M; Romero M; Roncero C; Saiz de la Hoya P; Sánchez Antolín G
    Rev Esp Enferm Dig; 2019 Nov; 111(11):862-873. PubMed ID: 31657609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elimination of hepatitis C. Positioning document of the Spanish Association for the Study of the Liver (AEEH).
    Crespo J; Albillos A; Buti M; Calleja JL; García-Samaniego J; Hernández-Guerra M; Serrano T; Turnes J; Acín E; Berenguer J; Berenguer M; Colom J; Fernández I; Fernández Rodríguez C; Forns X; García F; Rafael Granados ; Lazarus JV; Molero JM; Molina E; Pérez Escanilla F; Pineda JA; Rodríguez M; Romero M; Roncero C; Saiz de la Hoya P; Sánchez Antolín G
    Gastroenterol Hepatol; 2019 Nov; 42(9):579-592. PubMed ID: 31594683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis C: The beginning of the end-key elements for successful European and national strategies to eliminate HCV in Europe.
    Papatheodoridis GV; Hatzakis A; Cholongitas E; Baptista-Leite R; Baskozos I; Chhatwal J; Colombo M; Cortez-Pinto H; Craxi A; Goldberg D; Gore C; Kautz A; Lazarus JV; Mendão L; Peck-Radosavljevic M; Razavi H; Schatz E; Tözün N; van Damme P; Wedemeyer H; Yazdanpanah Y; Zuure F; Manns MP
    J Viral Hepat; 2018 Mar; 25 Suppl 1():6-17. PubMed ID: 29508946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Point-of-care hepatitis C testing and treatment strategy for people attending harm reduction and addiction centres for hepatitis C elimination.
    Forns X; Colom J; García-Retortillo M; Quer JC; Lens S; Martró E; Domínguez-Hernández R; Casado MÁ; Buti M
    J Viral Hepat; 2022 Mar; 29(3):227-230. PubMed ID: 34806812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Introducing hepatitis C virus healthcare pathways in addiction care in the Netherlands with a Breakthrough project: a mixed method study.
    Kracht PAM; de Gee EA; van der Poel A; Verhagen MAMT; Hoepelman AIM; Croes EA; Arends JE
    Harm Reduct J; 2019 Jul; 16(1):45. PubMed ID: 31307470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis C elimination among people incarcerated in prisons: challenges and recommendations for action within a health systems framework.
    Akiyama MJ; Kronfli N; Cabezas J; Sheehan Y; Thurairajah PH; Lines R; Lloyd AR;
    Lancet Gastroenterol Hepatol; 2021 May; 6(5):391-400. PubMed ID: 33857445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lessons Learned From Global Hepatitis C Elimination Programs.
    Handanagic S; Shadaker S; Drobeniuc J; Tsereteli M; Alkhazashvili M; Adesigbin C; Adamu I; Adabe R; Agwuocha C; Adisa O; Azania A; Boeke CE; Ngwije A; Serumondo J; Armstrong PA
    J Infect Dis; 2024 May; 229(Supplement_3):S334-S341. PubMed ID: 37739781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Innovations in Hepatitis C Screening and Treatment.
    Patel AA; Bui A; Prohl E; Bhattacharya D; Wang S; Branch AD; Perumalswami PV
    Hepatol Commun; 2021 Mar; 5(3):371-386. PubMed ID: 33681673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis C disease burden and strategies for elimination by 2030 in Brazil. A mathematical modeling approach.
    Benzaken AS; Girade R; Catapan E; Pereira GFM; Almeida EC; Vivaldini S; Fernandes N; Razavi H; Schmelzer J; Ferraz ML; Ferreira PRA; Pessoa MG; Martinelli A; Souto FJD; Walsh N; Mendes-Correa MC
    Braz J Infect Dis; 2019; 23(3):182-190. PubMed ID: 31145876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elimination of Hepatitis C Virus in Australia: Laying the Foundation.
    Dore GJ; Hajarizadeh B
    Infect Dis Clin North Am; 2018 Jun; 32(2):269-279. PubMed ID: 29778255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Milestones to reach Hepatitis C Virus (HCV) elimination in Italy: From free-of-charge screening to regional roadmaps for an HCV-free nation.
    Kondili LA; Aghemo A; Andreoni M; Galli M; Rossi A; Babudieri S; Nava F; Leonardi C; Mennini FS; Gardini I; Russo FP
    Dig Liver Dis; 2022 Feb; 54(2):237-242. PubMed ID: 33926816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the Cherokee Nation Hepatitis C Virus Elimination Program in the First 22 Months of Implementation.
    Mera J; Williams MB; Essex W; McGrew KM; Boeckman L; Gahn D; Miller A; Durham D; Fox J; David C; Ritter T; Jones S; Bouse S; Galvani A; Ward JW; Drevets DA; Carabin H
    JAMA Netw Open; 2020 Dec; 3(12):e2030427. PubMed ID: 33337496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tailored screening and dedicated funding for direct acting antiviral drugs: how to keep Italy on the road to hepatitis C virus elimination?
    Kondili LA; Blach S; Razavi H; Craxì A
    Ann Ist Super Sanita; 2020; 56(3):325-329. PubMed ID: 32959798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eliminating hepatitis C on the Balearic Islands, Spain: a protocol for an intervention study to test and link people who use drugs to treatment and care.
    Lazarus JV; Herranz A; Picchio CA; Villota-Rivas M; Rodríguez A; Alonso JM; Moratinos A; Perrotta A; Tegeo E; Bibiloni F; Buti M; Vilella À
    BMJ Open; 2021 Oct; 11(10):e053394. PubMed ID: 34675021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Remaining challenges in HCV elimination.
    Capraru C; Feld JJ
    J Hepatol; 2021 Apr; 74(4):964-965. PubMed ID: 33589319
    [No Abstract]   [Full Text] [Related]  

  • 17. Economic evaluation of the hepatitis C elimination strategy in Greece in the era of affordable direct-acting antivirals.
    Gountas I; Sypsa V; Papatheodoridis G; Souliotis K; Athanasakis K; Razavi H; Hatzakis A
    World J Gastroenterol; 2019 Mar; 25(11):1327-1340. PubMed ID: 30918426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What is needed to achieve HCV microelimination among HIV-infected populations in Andalusia, Spain: a modeling analysis.
    Skaathun B; Borquez A; Rivero-Juarez A; Mehta SR; Tellez F; Castaño-Carracedo M; Merino D; Palacios R; Macías J; Rivero A; Martin NK
    BMC Infect Dis; 2020 Aug; 20(1):588. PubMed ID: 32770955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Launch of a Nationwide Hepatitis C Elimination Program--Georgia, April 2015.
    Mitruka K; Tsertsvadze T; Butsashvili M; Gamkrelidze A; Sabelashvili P; Adamia E; Chokheli M; Drobeniuc J; Hagan L; Harris AM; Jiqia T; Kasradze A; Ko S; Qerashvili V; Sharvadze L; Tskhomelidze I; Kvaratskhelia V; Morgan J; Ward JW; Averhoff F
    MMWR Morb Mortal Wkly Rep; 2015 Jul; 64(28):753-7. PubMed ID: 26203628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Key Role of Multidisciplinary Collaboration towards Global Elimination of HCV Infection.
    Krekulova L; Oktabec Z; Riley LW
    Int J Environ Res Public Health; 2022 Mar; 19(7):. PubMed ID: 35409839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.